Know Cancer

or
forgot password

Randomized Trial of the Effectiveness of a Nurse Education and Care Program for Breast Cancer Patients Treated With Chemotherapy


N/A
18 Years
N/A
Not Enrolling
Female
Breast Cancer

Thank you

Trial Information

Randomized Trial of the Effectiveness of a Nurse Education and Care Program for Breast Cancer Patients Treated With Chemotherapy


Design: randomized controlled clinical trial with non-pharmacologic intervention. Subjects
and setting of study: patients with breast cancer who initiate adjuvant, neoadjuvant or
palliative chemotherapy, in the Day Unit of a University Hospital. Interventions: random
allocation of the patients in two arms according to the nursing cares. The arm A is the one
of standard education and care. They consist of receiving programmed oral and written
information by the specialist in Medical Oncology before initiating the chemotherapy
treatment and before each cycle of treatment. Also, the patients will be able to ask for
information to the nurses when they need it. Arm B is the one of experimental education and
care. They consist of receiving oral and written information by the specialist before
initiating the chemotherapy treatment and before each cycle. In addition, the patients
assigned to arm B will receive programmed education and care about the chemotherapy by a
nurse of the Medical Oncology service before the beginning of the treatment and in each
cycle, in a specific nurse consultation. Determinations: use of health resources (not
programmed attendance in Primary, Specialist and Emergency care or hospitalisation).
Toxicity caused by the chemotherapy. Patients who leave the chemotherapy by serious
toxicity. Quality of life measured by means of the EORTC QOL-C30 questionnaire. Satisfaction
with the received medical assistance.


Inclusion Criteria:



- Patients with breast cancer who initiate adjuvant, neoadjuvant or palliative
chemotherapy.

- Performance status 0-2 (ECOG).

- Outpatients.

- Normal hematopoietic, hepatic, renal, cardiac and lung functions.

- Must be able to sign the informed consent

Exclusion Criteria:

- Contraindication for chemotherapy

- Inpatients

- Simultaneously radiotherapy and endocrine therapy.

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care

Outcome Measure:

Use of health resources (not programmed attendance in Primary, Specialist and Emergency care or hospitalisation).

Outcome Time Frame:

one year

Safety Issue:

Yes

Principal Investigator

José M. Baena-Cañada, MD; PhD

Investigator Role:

Study Director

Investigator Affiliation:

Oncology Unit, Hospital Universitario Puerta del Mar, Cádiz, Spain

Authority:

Spain: Ethics Committee

Study ID:

PI070141

NCT ID:

NCT00964522

Start Date:

January 2007

Completion Date:

March 2011

Related Keywords:

  • Breast Cancer
  • Quality of life
  • Breast Cancer
  • Nursing Care
  • Education
  • Chemotherapy
  • Breast Neoplasms

Name

Location